` 2415 (MedSci Healthcare Holdings Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

M
2415
vs
H
Hang Seng (Hong Kong)

Over the past 12 months, MedSci Healthcare Holdings Ltd has underperformed Hang Seng (Hong Kong), delivering a return of +15% compared to the Hang Seng (Hong Kong)'s +16% growth.

Stocks Performance
2415 vs Hang Seng (Hong Kong)

Loading
2415
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
2415 vs Hang Seng (Hong Kong)

Performance Gap Between 2415 and HSI
HIDDEN
Show

Performance By Year
2415 vs Hang Seng (Hong Kong)

Loading
2415
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
MedSci Healthcare Holdings Ltd vs Peers

Hang Seng (Hong Kong)
2415
VEEV
EIS
SMART
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

MedSci Healthcare Holdings Ltd
Glance View

Market Cap
752.9m HKD
Industry
Health Care

MedSci Healthcare Holdings Ltd. operates an online professional physician platform in China. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2023-04-27. The firm mainly provides omni-channel marketing solutions, physician platform solutions, real world study solutions, clinical research auxiliary services, digital therapeutic solutions, virtual reality diagnosis, prognosis modeling services and chronic disease management services. The firm mainly operates its businesses in the domestic and overseas markets.

MedSci Healthcare Holdings Ltd Intrinsic Value
HIDDEN
Show
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett